X4 Pharmaceuticals Inc (XFOR)
0.3552
+0.08
(+29.49%)
USD |
NASDAQ |
Nov 14, 12:33
X4 Pharmaceuticals Total Assets (Quarterly): 210.61M for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 210.61M |
| March 31, 2024 | 112.18M |
| December 31, 2023 | 147.26M |
| September 30, 2023 | 173.29M |
| June 30, 2023 | 173.40M |
| March 31, 2023 | 124.40M |
| December 31, 2022 | 155.59M |
| September 30, 2022 | 113.41M |
| June 30, 2022 | 81.02M |
| March 31, 2022 | 99.62M |
| December 31, 2021 | 117.18M |
| September 30, 2021 | 120.52M |
| June 30, 2021 | 141.66M |
| March 31, 2021 | 161.04M |
| December 31, 2020 | 122.87M |
| Date | Value |
|---|---|
| September 30, 2020 | 133.13M |
| June 30, 2020 | 142.53M |
| March 31, 2020 | 153.72M |
| December 31, 2019 | 160.70M |
| September 30, 2019 | 109.54M |
| June 30, 2019 | 133.51M |
| March 31, 2019 | 62.55M |
| December 31, 2018 | 36.00M |
| September 30, 2018 | 45.90M |
| June 30, 2018 | 57.21M |
| March 31, 2018 | 69.22M |
| December 31, 2017 | 81.25M |
| September 30, 2017 | 37.16M |
| December 31, 2016 | 7.604M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
81.02M
Minimum
Jun 2022
210.61M
Maximum
Jun 2024
139.16M
Average
141.66M
Median
Jun 2021
Total Assets (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 3.925M |
| Palatin Technologies Inc | 10.74M |
| iBio Inc | 28.73M |
| Theriva Biologics Inc | 42.39M |
| Oragenics Inc | 2.710M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 116.16M |
| Shareholders Equity (Quarterly) | 94.45M |
| Debt to Equity Ratio | 0.7944 |
| Current Ratio | 6.069 |
| Net Debt Paydown Yield | -8.74% |